Advisors Asset Management, Inc. Exact Sciences Corp Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 28,650 shares of EXAS stock, worth $1.42 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

28,650

Previous 28,248 1.42%

Holding current value

$1.42 Million

Previous $1.19 Million 63.45%

% of portfolio

0.04%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$42.43 - $70.83 $17,056 - $28,473	402 Added 1.42%	28,650 $1.95 Million
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $352,586 - $633,512	-8,531 Reduced 23.2%	28,248 $1.19 Million
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $426,188 - $558,733	7,574 Added 25.93%	36,779 $2.54 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $601,821 - $771,586	10,190 Added 53.59%	29,205 $2.16 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $325,058 - $492,929	5,186 Added 37.5%	19,015 $1.79 Million
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $447,549 - $671,182	9,484 Added 218.27%	13,829 $937,000
Q4 2022 Feb 13, 2023	SELL	$30.35 - $53.15 $77,271 - $135,319	-2,546 Reduced 36.95%	4,345 $215,000
Q3 2022 Nov 08, 2022	SELL	$31.97 - $49.37 $17,519 - $27,054	-548 Reduced 7.37%	6,891 $224,000
Q2 2022 Aug 08, 2022	SELL	$35.61 - $76.23 $298,554 - $639,112	-8,384 Reduced 52.99%	7,439 $293,000
Q1 2022 May 17, 2022	BUY	$57.56 - $82.54 $2,014 - $2,888	35 Added 0.22%	15,823 $1.11 Million
Q4 2021 Feb 15, 2022	BUY	$72.5 - $100.68 $48,140 - $66,851	664 Added 4.39%	15,788 $1.23 Million
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $185,984 - $255,667	-2,061 Reduced 11.99%	15,124 $1.44 Million
Q2 2021 Jul 30, 2021	BUY	$93.66 - $139.27 $285,194 - $424,077	3,045 Added 21.53%	17,185 $2.14 Million
Q1 2021 May 07, 2021	BUY	$116.57 - $155.01 $408,577 - $543,310	3,505 Added 32.96%	14,140 $1.86 Million
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $34,963 - $49,884	-351 Reduced 3.19%	10,635 $1.41 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $305,461 - $427,319	-4,189 Reduced 27.6%	10,986 $1.12 Million
Q2 2020 Aug 12, 2020	BUY	$55.75 - $92.75 $31,164 - $51,847	559 Added 3.82%	15,175 $1.32 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $106,195 - $292,640	-2,802 Reduced 16.09%	14,616 $848,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $736,915 - $946,432	9,489 Added 119.67%	17,418 $1.61 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $295,419 - $400,419	3,269 Added 70.15%	7,929 $717,000
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $55,317 - $72,948	618 Added 15.29%	4,660 $550,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $25,039 - $38,986	404 Added 11.11%	4,042 $350,000
Q4 2018 Jan 31, 2019	BUY	$56.04 - $82.66 $146,600 - $216,238	2,616 Added 255.97%	3,638 $230,000
Q3 2018 Nov 15, 2018	BUY	$48.29 - $80.6 $49,352 - $82,373	1,022 New	1,022 $81,000

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.77B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Exact Sciences Corp Transaction History